Previous close | 53.75 |
Open | 53.93 |
Bid | 54.16 x 0 |
Ask | 54.29 x 0 |
Day's range | 53.93 - 53.99 |
52-week range | 53.04 - 155.96 |
Volume | |
Avg. volume | 622 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 Oct 2024 - 04 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Moderna (MRNA) concluded the recent trading session at $58.39, signifying a -0.56% move from its prior day's close.
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for manufacturers.
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Jim Cramer stocks that finished dead last. In a recent episode of Mad Money, Jim Cramer examined market trends of the […]